Askpot
← Company directory

oncomed: SWOT analysis

oncomed is a Contract Development and Manufacturing Organization (CDMO) specializing in the aseptic processing of oncology injectables. The company delivers high-potent and cytotoxic drugs worldwide to combat cancer.

Strengths

  • Oncomed possesses specialized knowledge in oncology, which enhances its credibility and appeal to pharmaceutical companies focused on cancer treatments.

  • The company is committed to quality and safety, ensuring that its products meet stringent regulatory standards, which is crucial in the pharmaceutical industry.

  • Oncomed offers rapid and flexible manufacturing solutions, allowing clients to adapt quickly to changing market demands and mitigate supply chain risks.

  • The organization has access to free manufacturing capacity with two operational lines, enabling it to scale production efficiently as client needs grow.

  • Oncomed utilizes state-of-the-art technology for advanced drug solutions, positioning itself as a leader in the CDMO space for oncology injectables.

  • The company emphasizes transparency in its service offerings, which minimizes additional investments for clients and builds trust.

  • Oncomed's commitment to social responsibility and ethical practices enhances its brand reputation and aligns with the values of many healthcare organizations.

  • As a subsidiary of medac GmbH, Oncomed benefits from the parent company's established reputation and resources in the pharmaceutical sector.

Weaknesses

Sign in to access Weaknesses

This content is available to registered users.

Sign in

Opportunities

Sign in to access Opportunities

This content is available to registered users.

Sign in

Threats

Sign in to access Threats

This content is available to registered users.

Sign in